XM does not provide services to residents of the United States of America.
W
W

Walgreens


News

Walgreens Has Closed 484 And 625 Stores In The UK And U.S., Respectively

BRIEF-Walgreens Has Closed 484 And 625 Stores In The UK And U.S., Respectively March 28 (Reuters) - Walgreens Boots Alliance Inc WBA.O : WALGREENS - AS OF FEBRUARY 29, 2024, THE COMPANY HAS CLOSED 484 AND 625 STORES IN THE UK AND U.S., RESPECTIVELY WALGREENS - DURING THE THREE AND SIX MONTHS ENDED FEBRUARY 29, 2024, VILLAGEMD APPROVED THE CLOSURE O
W

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ +3.6% Old Dominion Freight Line Inc ODFL.OQ +2.6% Analog Devices Inc ADI.OQ +2.3% Fortinet Inc FTNT.OQ +1.7% American Electric Power Company Inc AEP.OQ +1.5% Bottom Performers Percent Change Moderna Inc MRNA.OQ -3.2% Tesla Inc TSLA.OQ -2.4% ON Semiconductor Corp ON.OQ -2.3% Marvell Technology Inc MRVL.OQ -2.0% Coca-Cola Europacific Partners PLC
F
M
T
W
A
O
U
O

S&P 500 top and bottom performing stocks at about 03:31 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:31 p.m. EDT S&P 500 .SPX Top Performers Percent Change Estee Lauder Companies Inc EL.N +6.1% AES Corp AES.N +4.2% Walgreens Boots Alliance Inc WBA.OQ +3.7% Boston Properties Inc BXP.N +3.6% Capital One Financial Corp COF.N +3.0% Bottom Performers Percent Change Carnival Corp CCL.N -4.2% Mo
T
W
O
U
E

Walgreens Exec Says Having Active And Constructive Conversations With PBMs And Other Payers Around Cost-Plus Models

BRIEF-Walgreens Exec Says Having Active And Constructive Conversations With PBMs And Other Payers Around Cost-Plus Models March 28 (Reuters) - Walgreens Boots Alliance Inc WBA.O : WALGREENS EXEC SAYS HAVING ACTIVE AND CONSTRUCTIVE CONVERSATIONS WITH PHARMACY BENEFIT MANAGERS AND OTHER PAYERS AROUND COST-PLUS MODELS - CONF. CALL WALGREENS EXEC SAYS EXPECT FY24 COMPARABLE RETAIL SALES TO BE DOWN ABOUT 3% - CONF.
W

U.S. STOCKS Gold miners, B Riley, Xilio Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, B Riley, Xilio Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes were set to open flat on Thursday in thin trading ahead of Easter break, as investors awaited more data to gauge the Federal Reserve's policy path on the last business day of a strong first quarter.
B
W
U

Walgreens takes $5.8 bln hit on VillageMD bet amid CEO focus on profit

UPDATE 4-Walgreens takes $5.8 bln hit on VillageMD bet amid CEO focus on profit Adds management comments in paragraphs 3 and 6, investor comments in paragraphs 10 and 11, updates shares By Leroy Leo and Puyaan Singh March 28 (Reuters) - Walgreens Boots Alliance WBA.O recorded a $5.8 billion impairment charge on its investment in clinic operator VillageMD on Thursday, hit by a cost-cutting drive to shut down unprofitable sites.
W

Wall St set to open flat ahead of Easter break, eyes sharp Q1 gains

US STOCKS-Wall St set to open flat ahead of Easter break, eyes sharp Q1 gains There will be no US equities report on Friday on account of Good Friday. Reuters will resume coverage on Monday, April 1. Semiconductor index set to end Q1 up over 17% Dow close to hitting 40,000 mark Walgreens falls after narrowing FY profit forecast Futures: Dow up 0.03%, S&P down 0.02%, Nasdaq down 0.02% Updated at 8:10 a.m.
N
W
T
U
U
U

Walgreens Boots Alliance Inc reports results for the quarter ended in February - Earnings Summary

Walgreens Boots Alliance Inc reports results for the quarter ended in February - Earnings Summary Walgreens Boots Alliance Inc WBA.OQ reported quarterly adjusted earnings of $1.20​​ per share for the quarter ended in February, higher than the same quarter last year, when the company reported EPS of $1.16. The mean expectation of fifteen analysts for the quarter was for earnings of 82 cents per share.
W

Walgreens narrows 2024 profit forecast, takes impairment charge in Q2, shares fall

BUZZ-Walgreens narrows 2024 profit forecast, takes impairment charge in Q2, shares fall ** Shares of pharmacy chain Walgreens Boots Alliance WBA.O fall 1.6% to $20.69 premarket ** Co narrows its FY 2024 adj. EPS forecast to $3.20 to $3.35 from $3.20 to $3.50 ** Analysts expect FY 2024 adj. EPS to be $3.24 - LSEG ** WBA takes a $5.8 bln impairment charge related to its VillageMD business, which runs doctors' clinics, dragging it into a net loss of $5.9 bln for Q2 ** Co's Q2 adj.
W

Walgreens books $5.8-billion impairment charge on VillageMD investment

CORRECTED-UPDATE 2-Walgreens books $5.8-billion impairment charge on VillageMD investment Corrects company name in paragraph 1, a previous version had same error March 28 (Reuters) - Walgreen s Boots Alliance WBA.O cut the higher end of its profit forecast for fiscal-year 2024 on Thursday, citing economic headwinds in its retail operations, and took a $5.8-billion impairment charge related to its VillageMD business.
W

Walgreens Boots Alliance Reports Fiscal 2024 Q2 Results

BRIEF-Walgreens Boots Alliance Reports Fiscal 2024 Q2 Results March 28 (Reuters) - Walgreens Boots Alliance Inc WBA.O : WALGREENS BOOTS ALLIANCE REPORTS FISCAL 2024 SECOND QUARTER RESULTS U.S. RETAIL PHARMACY SEGMENT HAD Q2 SALES OF $28.9 BILLION, AN INCREASE OF 4.7 PERCENT FROM YEAR-AGO QUARTER REMAIN CONFIDENT IN OUR GOAL OF ACHIEVING $1 BILLION IN COST SAVINGS THIS YEAR CONTINUING TO STRATEGICALLY REVIEW OUR PORTFOLIO OVER NEXT THREE MONTHS IN AN EFFORT TO ENSURE IT DRIVES GROWTH AND DELIVERS
W

Walgreens narrows full-year profit forecast and takes $5.8 billion impairment

CORRECTED-Walgreens narrows full-year profit forecast and takes $5.8 billion impairment Corrects company name in paragraph 1 March 28 (Reuters) - Walgreens Boots Alliance WBA.O narrowed its profit forecast for fiscal 2024 by on Thursday, citing economic challenges for its retail business, and also took a $5.8 billion impairment related to its VillageMD business.
W

Walgreens Sees 2024 ADJ EPS Between $3.20 to $3.35

BRIEF-Walgreens Sees 2024 ADJ EPS Between $3.20 to $3.35 Mar 28 (Reuters) - Walgreens Q2 operating income USD -13,171 million. Q2 pretax profit USD -13,114 million vs. IBES estimate USD 720.6 million Q2 sales USD 37,052 million vs. IBES estimate USD 35,863 million Q2 EPS USD -6.85 Q2 adjusted net income USD 1,000 million vs. IBES estimate USD 692.7 million Q2 adjusted EPS USD 1.2 vs.
W

Unrushed Fed sees out buoyant Q1, dollar revs up

MORNING BID AMERICAS-Unrushed Fed sees out buoyant Q1, dollar revs up A look at the day ahead in U.S. and global markets from Mike Dolan With Wall St set for its final trading day of a bumper first quarter , the Federal Reserve seems in "no rush" to lower interest rates just yet - buoying the dollar as other central banks chomp at the bit. Fed Governor Christopher Waller set the tone for the Easter break on Wednesday indicating the central bank was being patient rather than hesitant in lowering
C
E
G
N
U
U
W
J
U
U

Walgreens sues to block ‘egregious’ $987 mln arbitration award

Walgreens sues to block ‘egregious’ $987 mln arbitration award By Mike Scarcella March 26 (Reuters) - Retail pharmacy giant Walgreens WBA.O has asked a Delaware federal judge to strike down what it called an “egregious and improper” arbitration award of nearly $1 billion for telemedicine provider PWNHealth in a contract dispute between the companies.
W

Pharmacies take appeal of $650 mln opioid award to Ohio top court

Pharmacies take appeal of $650 mln opioid award to Ohio top court Ohio Supreme Court weighs question of state law at 6th Circuit's request Case was first against pharmacies over opioids to go trial By Nate Raymond March 26 (Reuters) - Pharmacy operators CVS CVS.N , Walmart WMT.N and Walgreens WBA.O on Tuesday urged Ohio's highest court to conclude they cannot be held liable for fueling an opioid epidemic in two of the state's counties that won a $650.9 million judgment against them.
W

AstraZeneca sues Arkansas to block drug-discount program

AstraZeneca sues Arkansas to block drug-discount program By Mike Scarcella March 26 (Reuters) - Pharmaceutical giant AstraZeneca AZN.L has sued to block an Arkansas law that it said would unlawfully expand a federal drug-discount program to include for-profit pharmacy chains such as CVS and Walgreens. The Anglo-Swedish drugmaker's lawsuit , filed in Little Rock federal court on Monday against the Arkansas insurance department, said the state measure violates provisions of the U.S.
A
W

Walgreens Boots Alliance Inc <WBA.OQ> expected to post earnings of 82 cents a share - Earnings Preview

Walgreens Boots Alliance Inc expected to post earnings of 82 cents a share - Earnings Preview Walgreens Boots Alliance Inc WBA.OQ WBA.O is expected to show a rise in quarterly revenue when it reports results on March 28 for the period ending February 29 2024 The Deerfield Illinois-based company is expected to report a 2.9% increase in revenue to $35.863 billion from $34.86 billion a year ago, according to the mean estimate from 12 analysts, based on LSEG data.
W

What to Watch in the Week Ahead and on Monday, March 25

What to Watch in the Week Ahead and on Monday, March 25 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT ON MONDAY Federal Reserve Bank of Atlanta President Raphael Bostic is scheduled to participate in a moderated conversation on "Equitable Economic Development" before the University of Cincinn
C
W
M

U.S. earnings week ahead

DIARY-U.S. earnings week ahead March 22 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 26-Mar-2024 BMO MKC McCormick & Company Inc Q1 2024 McCormick & Company Inc Earnings Release 27-Mar-2024 BMO CTAS.O Cintas Corp Q3 2024 Cintas Corp Earnings Release 27-Mar-2024 BMO CCL Carnival Corp Q1 2024 Carnival Corp Earnings Release 27-Mar-202
C
P
W
U
M



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.